Clinical trial
Optimising Outpatient Care in Mild to Moderate Psoriasis by a Newly Developed 'Topical Treatment Optimising Programme' - an International Study Using Daivobet®/Dovobet® Gel
NCT01587755 is registered in ClinicalTrials.gov with Kristian Reich, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimising Outpatient Care in Mild to Moderate Psoriasis by a Newly Developed 'Topical Treatment Optimising Programme' - an International Study Using Daivobet®/Dovobet® Gel
- Lead sponsor
- Kristian Reich, MD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- June 30, 2014
- Enrollment
- 1,852 (actual)
- Sites
- 93
Conditions
As the registry lists them; a condition with its own page is linked.
mild to moderate psoriasis